GO
Loading...

CNBC's Huckman On Weight Loss/Diabetes Drug

We're keeping an eye on shares of Sanofi-Aventis . The company says a new study finds its acomplia weight loss drug can also help diabetes. CNBC's pharmaceutical reporter Mike Huckman had the details on "Squawk on the Street."

Huckman says acomplia could help control type 2 diabetes--and that test results also showed the raising of good cholesterol-by up to 16%. The drug could provide up to $5 billion dollars in sales revenues. The drug helps weight loss by curbing the appetite.

There's also another possibility for acomplia. Sanofi-Aventis might consider further tests with the drug to help stop smoking.

Symbol
Price
 
Change
%Change
SNI
---

Featured

Contact

  • Carl Quintanilla is an Emmy-winning reporter and co-anchor of CNBC's "Squawk on the Street," broadcast live from the NYSE.

  • Simon Hobbs co-anchors the 10 a.m. hour of CNBC's "Squawk on the Street" live from the New York Stock Exchange.

  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

  • “Squawk on the Street” Co-Anchor

  • Rick Santelli joined CNBC Business News as an on-air editor in 1999, reporting live from the floor of the Chicago Board of Trade.